Pricing Log in Create free account
Saturday 17 October 2026 Export BAX’s income statement to Excel — free account

Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Baxter International Inc. (BAX) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Baxter International Inc. (BAX) trades at a EV/Sales of 1.8×. Over the past ten years it has ranged from 1.4× (March 2026) to 4.9× (February 2022); the current reading is higher than 8% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.5× (37.57%)
FY2024 2.5× (15.77%)
FY2023 2.9× (27.54%)
FY2022 4.0× (15.08%)
FY2021 4.8× 28.28%
FY2020 3.7× (5.44%)
FY2019 3.9× 18.35%
FY2018 3.3× (4.11%)
FY2017 3.5× 44.92%
FY2016 2.4× 18.82%

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.6× 12.38%
Mar 2026 1.4× (7.64%)
Dec 2025 1.5× (12.87%)
Sep 2025 1.8× (17.59%)
42 more quarters

Against its own ten years

Low 1.4× High 4.9×
Ten-year median 3.3×
Current reading's percentile 9

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. 1.8×
BLCO Bausch + Lomb Corporation compare 2.0×
AVTR Avantor, Inc. compare 2.2×
ALGN Align Technology, Inc. compare 2.3×
ATR AptarGroup, Inc. compare 2.3×
SOLV Solventum Corporation compare 2.4×
COO The Cooper Companies, Inc. compare 3.2×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 12.3×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BAX